Wu Jun, Xu Jia-Hao, Zou Hao-Qi, Ouyang Yi-Jiang, Li Shang-Jie, Wu Liang, Zhang Jie, Yin Ming-Juan, Ye Dong-Qing, Ni Jin-Dong
Department of Epidemiology and Biostastics, School of Public Health, Shunde Women and Children's Hospital, Guangdong Medical University, Dongguan, China.
School of Public Health, Anhui University of Science and Technology, Hefei, Anhui, China.
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):1-11. doi: 10.1002/jcsm.13642. Epub 2024 Nov 25.
Bilirubin is a by-product of haemoglobin breakdown and has been reported to be a potent antioxidant recently. While elevated levels of bilirubin have been linked to a reduced risk of various diseases, their role remains unknown in frailty. This study aims to explore the relationship between serum bilirubin levels and the risk of frailty.
This cohort study included 442 223 White British participants (aged 39 to 73 years) with an available frailty index at baseline (2006 to 2010) from the UK Biobank. The associations of total/direct bilirubin levels with the continuous frailty index were analysed by multivariable linear regression, and multivariable logistic regression was used after classifying frailty outcomes into non-frailty, pre-frailty and frailty. A Mendelian randomization (MR) analysis was applied to evaluate the association of genetically predicted bilirubin levels with frailty risk.
The prevalence rates of both pre-frailty and frailty were 46.17% and 12.49%, respectively, with higher rates observed in women than in men (pre-frailty: 47.33% vs. 44.79%, frailty: 13.64% vs. 11.13%, respectively). There was a non-linear negative association between total bilirubin levels and frailty indexes (p < 0.0001). Mildly elevated total bilirubin levels had protective effects against pre-frailty (OR = 0.863, 95% CI: 0.849 to 0.879, p < 0.001) and frailty (OR = 0.660, 95% CI: 0.641 to 0.679, p < 0.001). Increased total bilirubin levels were more beneficial for women with frailty risk (percent changes per SD μmol/L = -0.37%, 95% CI: -0.40% to -0.34%). The MR analysis revealed a negative association between genetically predicted total/direct bilirubin levels and frailty risk (both p < 0.0001).
Circulating total/direct bilirubin levels were negatively associated with frailty risk in White British individuals. Mildly elevated total bilirubin levels were more beneficial for women subpopulation.
胆红素是血红蛋白分解的副产物,最近有报道称其是一种有效的抗氧化剂。虽然胆红素水平升高与多种疾病风险降低有关,但其在虚弱状态中的作用仍不明确。本研究旨在探讨血清胆红素水平与虚弱风险之间的关系。
这项队列研究纳入了英国生物银行中442223名英国白人参与者(年龄在39至73岁之间),他们在基线时(2006年至2010年)有可用的虚弱指数。通过多变量线性回归分析总胆红素/直接胆红素水平与连续虚弱指数之间的关联,并在将虚弱结局分为非虚弱、前期虚弱和虚弱后,使用多变量逻辑回归分析。应用孟德尔随机化(MR)分析来评估基因预测的胆红素水平与虚弱风险之间的关联。
前期虚弱和虚弱的患病率分别为46.17%和12.49%,女性患病率高于男性(前期虚弱:47.33%对44.79%,虚弱:13.64%对11.13%)。总胆红素水平与虚弱指数之间存在非线性负相关(p<0.0001)。总胆红素水平轻度升高对前期虚弱(OR=0.863,95%CI:0.849至0.879,p<0.001)和虚弱(OR=0.660,95%CI:0.641至0.679,p<0.001)具有保护作用。总胆红素水平升高对有虚弱风险的女性更有益(每标准差μmol/L的百分比变化=-0.37%,95%CI:-0.40%至-0.34%)。MR分析显示基因预测的总胆红素/直接胆红素水平与虚弱风险之间存在负相关(均p<0.0001)。
在英国白人个体中,循环总胆红素/直接胆红素水平与虚弱风险呈负相关。总胆红素水平轻度升高对女性亚人群更有益。